Kristen M. Beck & John Koo. 2021. Advances in Psoriasis. Advances in Psoriasis
71
91
.
Michael Abrouk, Mio Nakamura, Tian Hao Zhu, Benjamin Farahnik, Rasnik K. Singh, Kristina M. Lee, Margareth V. Jose, John Koo, Tina Bhutani & Wilson Liao. (2016) The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables. Dermatology and Therapy 6:3, pages 325-331.
Crossref
Tien V. Nguyen & John Y. M. Koo. 2014. Advances in Psoriasis. Advances in Psoriasis
91
110
.
Fahad Almutawa, Naif Alnomair, Yun Wang, Iltefat Hamzavi & Henry W. Lim. (2013) Systematic Review of UV-Based Therapy for Psoriasis. American Journal of Clinical Dermatology 14:2, pages 87-109.
Crossref
Argentina Leon, Wilson J. Liao, Rishu Gupta, John Y. M. Koo & Jashin J. Wu. (2018) Tumor Necrosis Factor-α Triad: Psoriasis, Cardiovascular Disease, and Depression. Psoriasis Forum 19a:1, pages 41-49.
Crossref
Ethan C. Levin, Rishu Gupta & Kanade Shinkai. (2018) Duration of Remission of Topical Psoriasis Therapies. Psoriasis Forum 19a:1, pages 22-33.
Crossref
Kenneth Gordon, Kim Papp, Yves Poulin, Yihua Gu, Stephen Rozzo & Eric H. Sasso. (2012) Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL. Journal of the American Academy of Dermatology 66:2, pages 241-251.
Crossref
Steven R FeldmanLee Eric SHeller Misha MKamangar FaranakPark KellyKoo John YM. 2011. Current and Emerging Treatments for Psoriasis. Current and Emerging Treatments for Psoriasis
60
71
.
B. Pedro Lobos & L. Gonzalo Eguiguren. (2011) Piel en el siglo XXI. Revista Médica Clínica Las Condes 22:6, pages 713-721.
Crossref
J.-H. Saurat, R.G. Langley, K. Reich, K. Unnebrink, E.H. Sasso & W. Kampman. (2011) Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study. British Journal of Dermatology 165:2, pages 399-406.
Crossref
Yukari OKUBO, Shoko NATSUME, Kae USUI, Misato AMAYA & Ryoji TSUBOI. (2011) Low-dose, short-term ciclosporin (Neoral®) therapy is effective in improving patients’ quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients. The Journal of Dermatology 38:5, pages 465-472.
Crossref
Janet E Angus, Ray Jobling, Hywel C Williams, Ingvil Saeterdal, Catherine Roberts & Elmer Villanueva. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Michael J. Murphy, Carlo Pincelli, Diane M. Hoss & Riccardo G. Borroni. 2011. Molecular Diagnostics in Dermatology and Dermatopathology. Molecular Diagnostics in Dermatology and Dermatopathology
419
441
.
Kristine Busse & John Koo. (2018) A Practical Approach to the Use of Methotrexate. Psoriasis Forum 16a:3, pages 48-59.
Crossref
Lenka Borska, Ctirad Andrys, Jan Krejsek, Kvetoslava Hamakova, Jan Kremlacek, Vladimir Palicka, Dianna Ranna & Zdenek Fiala. (2010) Genotoxic and apoptotic effects of Goeckerman therapy for psoriasis. International Journal of Dermatology 49:3, pages 289-294.
Crossref
Josep Manel Casanova, Verónica Sanmartín, Xavier Soria, Marta Ferran, Ramon M. Pujol & Miquel Ribera. (2009) Tratamiento tópico de la psoriasis. Piel 24:10, pages 556-567.
Crossref
Torello Lotti, Lara Tripo, Marta Grazzini, Alena Krysenka, Gionata Buggiani & Vincenzo De Giorgi. (2009)
Focused UV-B narrowband microphototherapy (Biopsorin
®
). A new treatment for plaque psoriasis
. Dermatologic Therapy 22:4, pages 383-385.
Crossref
Rebeca de Miguel & Rokea el-Azhary. (2009) Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis. International Journal of Dermatology 48:6, pages 653-658.
Crossref
CM Witt, R Lüdtke & SN Willich. (2009) Homeopathic treatment of patients with psoriasis - a prospective observational study with 2 years follow-up. Journal of the European Academy of Dermatology and Venereology 23:5, pages 538-543.
Crossref
L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, J.M. Hernanz, J.L. López-Estebaranz, J.C. Moreno, J.L. Sánchez-Carazo, F. Vanaclocha & H. Vázquez-Veiga. (2009) Consensus Document on the Evaluation and Treatment of Moderate to Severe Psoriasis. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliográficas (English Edition) 100:4, pages 277-288.
Crossref
L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, J.M. Hernanz, J.L. López-Estebaranz, J.C. Moreno, J.L. Sánchez-Carazo, F. Vanaclocha & H. Vázquez-Veiga. (2009) Documento de consenso sobre la evaluación y el tratamiento de la psoriasis moderada/grave del Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología. Actas Dermo-Sifiliográficas 100:4, pages 277-286.
Crossref
Carlo Pincelli, Marco Pignatti & Riccardo G. Borroni. (2009) Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy. Experimental Dermatology 18:4, pages 337-349.
Crossref
A. Levy-Roy, R. Porcher, A.-L. de Fonclare, P. Morel & A. Dupuy. (2009) Efficacité des anti-TNF-α dans le psoriasis : revue systématique et représentation graphique. Annales de Dermatologie et de Vénéréologie 136:4, pages 315-322.
Crossref
M. Caproni, E. Antiga, L. Melani, W. Volpi, E. Del Bianco & P. Fabbri. (2008) Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial. Journal of Clinical Immunology 29:2, pages 210-214.
Crossref
Mark Chaballa, Joanne Filicko-O'Hara, Dorothy Holt, Adam M. Frank, John L. Wagner, Dolores Grosso & Neal Flomenberg. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
1269
1294
.
Mark R. Pittelkow & Joseph Genebriera. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
983
1005
.
Harald Gollnick. 2009. Braun-Falco’s Dermatology. Braun-Falco’s Dermatology
1573
1593
.
Sibel Ersoy-Evans, Aslı Altaykan, Sedef Şahin & Fikret Kölemen. (2008) Phototherapy in Childhood. Pediatric Dermatology 25:6, pages 599-605.
Crossref
Gianfranco Altomare, Fabio Ayala, Enzo Berardesca, Sergio Chimenti, Alberto Giannetti, Giampiero Girolomoni, Torello Lotti, Patrizia Martini, Andrea Peserico, Antonio Puglisi Guerra & Gino A. Vena. (2008) Etanercept provides a more physiological approach in the treatment of psoriasis. Dermatologic Therapy 21, pages S1-S14.
Crossref
Lenka Borska, Ctirad Andrys, Jan Krejsek, Kvetoslava Hamakova, Jan Kremlacek, Karel Ettler & Zdenek Fiala. (2008) Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen. International Journal of Dermatology 47:8, pages 800-805.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:12.
Crossref
A MacDonald & A D Burden. (2007) Psoriasis: advances in pathophysiology and management. Postgraduate Medical Journal 83:985, pages 690-697.
Crossref